Compare NUE & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUE | BDX |
|---|---|---|
| Founded | 1905 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.0B | 49.4B |
| IPO Year | 1994 | 1998 |
| Metric | NUE | BDX |
|---|---|---|
| Price | $244.65 | $184.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $209.60 | $186.00 |
| AVG Volume (30 Days) | 1.0M | ★ 1.5M |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | 1.01% | ★ 2.89% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.27 | 1.59 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $12.07 | N/A |
| Revenue Next Year | $4.14 | $3.02 |
| P/E Ratio | ★ $29.89 | $115.32 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $131.32 | $140.11 |
| 52 Week High | $280.11 | $213.08 |
| Indicator | NUE | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 41.11 | 52.81 |
| Support Level | $241.98 | $175.20 |
| Resistance Level | $268.03 | $186.99 |
| Average True Range (ATR) | 6.57 | 3.81 |
| MACD | -1.43 | -0.49 |
| Stochastic Oscillator | 9.01 | 68.33 |
Nucor Corp manufactures steel and steel products. The company's reportable segments are steel mills, steel products, and raw materials. The majority of its revenue is derived from the steel mills segment, which is engaged in producing sheet steel (hot-rolled, cold-rolled, and galvanized), plate steel, structural steel (wide-flange beams, beam blanks, H-piling, and sheet piling), and bar steel products. Nucor manufactures steel principally from scrap steel and scrap steel substitutes using electric arc furnaces (EAFs), along with continuous casting and automated rolling mills. The steel mills segment sells its products mainly to steel service centers, fabricators, and manufacturers located in the United States, Canada, and Mexico.
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.